What is Sailong Pharmaceutical Group Co Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sailong Pharmaceutical Group Co Enterprise Value Chart
Competitive Comparison of Sailong Pharmaceutical Group Co's Enterprise Value
For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sailong Pharmaceutical Group Co's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sailong Pharmaceutical Group Co's Enterprise Value falls into.
Sailong Pharmaceutical Group Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sailong Pharmaceutical Group Co (SZSE:002898) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sailong Pharmaceutical Group Co's EV-to-EBIT for today is
Sailong Pharmaceutical Group Co's current Enterprise Value is ¥1,679.0 Mil.
Sailong Pharmaceutical Group Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥27.8 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sailong Pharmaceutical Group Co's EV-to-EBITDA for today is:
Sailong Pharmaceutical Group Co's current Enterprise Value is ¥1,679.0 Mil.
Sailong Pharmaceutical Group Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥27.8 Mil.
Sailong Pharmaceutical Group Co's current Enterprise Value is ¥1,679.0 Mil.
Sailong Pharmaceutical Group Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥300.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sailong Pharmaceutical Group Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sailong Pharmaceutical Group Co (SZSE:002898) Business Description
Zhuhai Sailong Pharmaceutical Co Ltd is the pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002898 has been successfully added to your 